UPDATE: Imprimis Pharma (IMMY) Reports Q4 EPS of -$0.44
Tweet
Share
E-mailGet Alerts IMMY Hot Sheet
Join SI Premium – FREE
(Updated - March 21, 2017 4:11 PM EDT)
Imprimis Pharma (NASDAQ: IMMY) reported Q4 EPS of ($0.44). Revenue for the quarter came in at $5.8 million.
For earnings history and earnings-related data on Imprimis Pharma (IMMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- BMO starts chip stocks coverage: Here are its preferred picks
- Deere & Co. (DE) Tops Q3 EPS by 41c, raises guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
